Search research articles
Contact Us
Filters
Showing results (251-260 of 525) with videos related to
Page
of 53
Sort By:
Addiction (Abingdon, England)
|
March 24, 2005
Evaluating explanations of the Australian 'heroin shortage'
Louisa Degenhardt, Peter Reuter, Linette Collins, et al.
Addiction (Abingdon, England)
|
February 28, 2002
Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS)
Shane Darke, Ibby Topp, Harlene Kaye, et al.
Suicide & Life-Threatening Behavior
|
November 26, 2009
Mental disorders and socioeconomic status: impact on population risk of attempted suicide in australia
Andrew Page, Richard Taylor, Wayne Hall, et al.
Drug and Alcohol Review
|
January 18, 2019
Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates
Gary Chung Kai Chan, Janni Leung, Wayne Hall
Addiction (Abingdon, England)
|
July 23, 2014
Collecting real-time data from substance users raises unique legal and ethical issues: reply to Kuntsche & Labhart
Carla Meurk, Wayne Hall, Adrian Carter, et al.
The International Journal on Drug Policy
|
August 13, 2019
Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada
Benedikt Fischer, Wayne Jones, Wayne Hall, et al.
Addiction (Abingdon, England)
|
July 30, 2019
The changing patterns and correlates of population-level polysubstance use in Australian youth: a multi-group latent class analysis of nationally representative samples spanning 12 years
Gary Chan, Jason Connor, Wayne Hall, et al.
Addiction (Abingdon, England)
|
September 12, 2012
Commentary on Kelty & Hulse (2012): is the comparison of mortality between patients prescribed implanted or oral naltrexone an unbiased and unconfounded comparison?
Matt Hickman, Louisa Degenhardt, Michael Farrell, et al.
Drug and Alcohol Review
|
July 21, 2022
A critical analysis of 'Electronic cigarettes and health outcomes: Systematic review of global evidence'
Colin Paul Mendelsohn, Alex Wodak, Wayne Hall, et al.
Eclinicalmedicine
|
April 8, 2020
Initial indicators of the public health impacts of non-medical cannabis legalization in Canada
Benedikt Fischer, Angelica Lee, Caroline O'Keefe-Markman, et al.
Page
of 53
Search research articles
Search
Showing results (251-260 of 525) with videos related to
Sort By:
Page
of 53
Addiction (Abingdon, England)
|
March 24, 2005
Evaluating explanations of the Australian 'heroin shortage'
Louisa Degenhardt, Peter Reuter, Linette Collins, et al.
Addiction (Abingdon, England)
|
February 28, 2002
Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS)
Shane Darke, Ibby Topp, Harlene Kaye, et al.
Suicide & Life-Threatening Behavior
|
November 26, 2009
Mental disorders and socioeconomic status: impact on population risk of attempted suicide in australia
Andrew Page, Richard Taylor, Wayne Hall, et al.
Drug and Alcohol Review
|
January 18, 2019
Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates
Gary Chung Kai Chan, Janni Leung, Wayne Hall
Addiction (Abingdon, England)
|
July 23, 2014
Collecting real-time data from substance users raises unique legal and ethical issues: reply to Kuntsche & Labhart
Carla Meurk, Wayne Hall, Adrian Carter, et al.
The International Journal on Drug Policy
|
August 13, 2019
Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada
Benedikt Fischer, Wayne Jones, Wayne Hall, et al.
Addiction (Abingdon, England)
|
July 30, 2019
The changing patterns and correlates of population-level polysubstance use in Australian youth: a multi-group latent class analysis of nationally representative samples spanning 12 years
Gary Chan, Jason Connor, Wayne Hall, et al.
Addiction (Abingdon, England)
|
September 12, 2012
Commentary on Kelty & Hulse (2012): is the comparison of mortality between patients prescribed implanted or oral naltrexone an unbiased and unconfounded comparison?
Matt Hickman, Louisa Degenhardt, Michael Farrell, et al.
Drug and Alcohol Review
|
July 21, 2022
A critical analysis of 'Electronic cigarettes and health outcomes: Systematic review of global evidence'
Colin Paul Mendelsohn, Alex Wodak, Wayne Hall, et al.
Eclinicalmedicine
|
April 8, 2020
Initial indicators of the public health impacts of non-medical cannabis legalization in Canada
Benedikt Fischer, Angelica Lee, Caroline O'Keefe-Markman, et al.
Page
of 53